S‐adenosyl‐l‐methionine (SAMe) as antidepressant: meta‐analysis of clinical studies

Acta Neurologica Scandinavica

Volumn 89, Issue 154 S, 1994, Pages 7-14

  Bressa, G M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

depression; meta analysis.; s adenosyl l methionine (SAMe)

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; IMIPRAMINE; MINAPRINE; NOMIFENSINE; PLACEBO; S ADENOSYLMETHIONINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ARTICLE; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLINICAL TRIALS; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; HUMAN; PLACEBOS; PROSPECTIVE STUDIES; S-ADENOSYLMETHIONINE; TREATMENT OUTCOME;

EID: 0028189416     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1994.tb05403.x     Document Type: Article

References (53)

1. Psychopharmacology today
2. The neuropharmacology of S‐adenosyl‐L‐methionine
3. Le transmetilazioni SAM‐dipendenti nelle sindromi depressive. Valutazione dell‐effetto terapeutico della S‐adenosilmetionina con la scala di Hamilton
4. The potential impact of meta‐analysis on medical care
5. Considerations for the meta‐analysis of randomized clinical trials: summary of a panel discussion
6. Effetti terapeutici e meccanismo d'azione della S‐adenosil‐l‐metionina (SAMe) nelie sindromi depressive
7. Therapy of schizophrenia and depressive disorders with s‐adenosyl‐l‐methionine
8. Disturbi neuropsichiatrici e transmetilazioni. Effetti terapeutici della S‐adenosil‐l‐metionina
9. Sindromi depressive, malattie cutanee e transmetilazioni. Effetti terapeutici della s‐adenosyl‐l‐metionina
10. La s‐adenosil‐l‐metionina (SAMe) in geropsichiatria: uno studio clinico controllato “in aperto” nelle sindromi depressive dell'eta senile
11. Sugli effetti clinici della s‐adenosil‐l‐metionina (SAMe) nelle sindromi depressive
12. Evaluation of sadenosylmethionine (SAMe) effectiveness on depression
13. Switch mechanism in affective illness and s‐adenosylmethionine
14. An open trial of S‐adenosylmethionine for treatment of depression
15. The antidepressant potential of oral S‐adenosyl‐l‐methionine
16. Neuroendocrine effects of s‐adenosyl‐l‐methionine, a novel putative antidepressant
17. Effect of S‐adenosyl‐l‐methionine (SAMe) upon depressive symptoms
18. (SAMe) versus placebo: a double blind comparison in major depressive disorders
19. Antidepressant activity of S‐adenosyl methionine
20. Affective illness and s‐adenosyl methionine: a preliminary report
21. Treatment of depression in rheumatoid arthtritic patients. A comparison of S‐adenosylmethionine (Samyr) and placebo in a double‐blind study
22. S‐Adenosylmethionine in depression: a literature review and preliminary report
23. Oral S‐adenosylmethionine in depression: a randomized, double‐blind, placebo‐controlled trial
24. Double‐blind, placebo‐controlled study of s‐adenosyl‐l‐methionine in depressed post‐menopausal women
25. The thyrotropin response to thyrotropin‐releasing hormone as a predictor of response to treatment in depressed outpatients
26. Studio controllato in doppio cieco (SAMe‐imipramina) nelle sindromi depressive
27. Comparison between the antidepressant activity of S‐adenosyl‐l‐methionine (SAMe) and that of some tricyclic drugs
28. Has SAMe (Ado‐Met) an antidepressant effect? A preliminary trial versus chlorimipramine
29. Confronto clinico in doppio cieco della SAMe versus clorimipramina nelle sindromi depressive
30. Azione antidepressiva della SAMe a paragone della clorimipramina. Ipotesi interpretative del meccanismo d'azione
31. Studio degli effetti antidepressivi di un transmetilante biologico (s‐adenosil‐metionina‐ SAMe)
32. Azione antidepressiva della SAMe a confronto con il nomifensine maleato
33. Early clinical double‐blind study with S‐adenosyl‐l‐methionine: a new potential antidepressant
34. S‐adenosylmethionine treatment of depression: a controlled clinical trial
35. S‐adenosilmetionina. Valutazione dell‐efficacia della S'adenosil‐metionina nel trattamento delle sindromi depressive: studio clinico controllato versus minaprina
36. Oral s‐adenosylmethionine in the treatment of depression: a double‐blind comparison with desipramine. Study Report
37. Oral S‐adenosyl‐L‐Methionine in depression
38. A rating scale for depression
39. A simple, general purpose display of magnitude of experimental effect
40. Beta‐blockage during and after myocardial infarction: an overview of the randomized trials
41. A meta‐analsyis of antidepressant outcome under “blinder” conditions
42. Examining antidepressant effectiveness: findings, ambiguities, and some vexing puzzles
43. How to write a study protocol: a primer for the clinician
44. Blindness and the validity of the double‐blind procedure
45. Age‐related modification of dopaminergic and beta‐adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S‐adenosylmethionine
46. Effects of phenothiazine treatment on the physical properties of platelet membranes from psychiatric patients
47. Platelet membrane fluidity of Alzheimer's disease and major depression
48. S‐adenosyl‐l‐methionine in the treatment of Alzheimer's Disease
49. S‐adenosylmethionine as an antidepressant: a double blind trial versus placebo